Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 3,287 Shares

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CFO Michael F. Maclean sold 3,287 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $28.59, for a total transaction of $93,975.33. Following the completion of the sale, the chief financial officer now […]

Leave a Reply

Your email address will not be published.

Previous post Solstice Gold (CVE:SGC) Trading Down 16.7% – Here’s Why
Next post Peter Heerma Sells 1,584 Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) Stock